$aartipharmabounce or die zone here
added since my earlier entry was messed up on it and i recon this should run it back so long term play for me
close below H4 200 ema no bueno and opens up the door for red line below
25.15 INR
2.17 B INR
18.18 B INR
49.54 M
About AARTI PHARMALABS LTD
Sector
Headquarters
Mumbai
Founded
2019
Website
ISIN
INE0LRU01027
FIGI
BBG01B1YBKP4
Aarti Pharmalabs Ltd. engages in the manufacture and sale of pharmaceutical and nutraceutical products. It offers active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xathine derivatives. The company was founded on November 22, 2019 and is headquartered in Mumbai, India.
Aarti Pharma labs-Nice BreakoutAarti Pharma labs-Nice Breakout
Capital to be deployed -20k
Investing Price-675-685
Breakout Price -669
Stoploss -559
Targets -1150
#chennai #StockMarketindia #StockToWatch #StocksInFocus #stockstowatch #StocksToTrade
#aartipharmalabs
Darvas Box Strategy - Breakout StockDisclaimer: I am Not SEBI Register adviser, please take advise from your financial adviser before investing in any stocks.
Stock has given break out , buy above the High and do not forget to keep stop loss best suitable for swing trading. Keep this stock in watch list.
Target and Stop loss Shown on
Aarti Pharmalabs Limited (APL) BreakoutSector: Pharmaceuticals
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Median PE:-34.9
EPS in Rs:-24.86
NOTE:-
All the information provided is for educational and informational purposes only. .
I am NOT a SEBI registered advisor or a financial adviser.
AARTIPHARMSupport and Resistance Levels: In technical analysis, support and resistance levels are significant price levels where buying or selling interest tends to be strong. They are identified based on previous price levels where the price has shown a tendency to reverse or find support.
Aarti Pharmalabs Ltd
TARGET AND STOPLOSS IN CHART
Market Cap
₹ 4,170 Cr.
Current Price
₹ 460
High / Low
₹ 476 / 235
Stock P/E
22.0
Book Value
₹ 183
Dividend Yield
0.00 %
ROCE
16.1 %
ROE
13.2 %
Face Value
₹ 5.00
Promoter holding
46.3 %
EPS last year
₹ 21.4
EPS latest quarter
₹ 5.72
Debt
₹ 207 Cr.
Pledg
📈 Analysis of AARTIPHARM: A Bullish Opportunity Awaits? 📈Hello, fellow traders! 👋
Today's spotlight is on AARTIPHARM . After closely observing its four-hour time frame, here's what caught my attention:
1️⃣ Major Trend: The stock is confidently striding in an upward direction. Each stride it takes, it glances back at its support, reassuring itself bef
Base on Base breakout the stock retested after a base-on-base consolidation, the stock broke out with huge volume and decent fallow up with good volume is a good sign to enter the stock.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AARTIPHARM is 585.05 INR — it has increased by 1.11% in the past 24 hours. Watch AARTI PHARMALABS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AARTI PHARMALABS LTD stocks are traded under the ticker AARTIPHARM.
AARTIPHARM stock has fallen by −2.49% compared to the previous week, the month change is a −5.44% fall, over the last year AARTI PHARMALABS LTD has showed a 19.01% increase.
AARTIPHARM reached its all-time high on Aug 29, 2024 with the price of 721.70 INR, and its all-time low was 234.80 INR and was reached on Feb 3, 2023. View more price dynamics on AARTIPHARM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AARTIPHARM stock is 3.22% volatile and has beta coefficient of 0.57. Track AARTI PHARMALABS LTD stock price on the chart and check out the list of the most volatile stocks — is AARTI PHARMALABS LTD there?
Yes, you can track AARTI PHARMALABS LTD financials in yearly and quarterly reports right on TradingView.
AARTIPHARM net income for the last quarter is 546.23 M INR, while the quarter before that showed 554.53 M INR of net income which accounts for −1.50% change. Track more AARTI PHARMALABS LTD financial stats to get the full picture.
AARTI PHARMALABS LTD dividend yield was 0.69% in 2023, and payout ratio reached 12.53%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 3.18 K employees. See our rating of the largest employees — is AARTI PHARMALABS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AARTI PHARMALABS LTD EBITDA is 4.03 B INR, and current EBITDA margin is 19.51%. See more stats in AARTI PHARMALABS LTD financial statements.
Like other stocks, AARTIPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AARTI PHARMALABS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AARTI PHARMALABS LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AARTI PHARMALABS LTD stock shows the neutral signal. See more of AARTI PHARMALABS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.